The natural history of intermediate and critical vein graft stenosis: Recommendations for continued surveillance or repair

Joseph L Mills, Christopher L. Wixon, Donovan C. James, Jenifer Devine, Alex Westerband, John D Hughes

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: Duplex ultrasound surveillance (DUS) after autogenous lower extremity bypass grafting is controversial. Specific criteria mandating graft revision are not uniform. It has been suggested that grafts harboring critical stenoses undergo revision, whereas those with intermediate stenoses undergo arteriography with selective repair. We sought to define the natural history and determine the risk of graft occlusion associated with unrepaired vein graft stenoses. Methods: We analyzed serial vascular laboratory and clinical data of 156 autogenous infrainguinal vein grafts in 142 patients. Grafts were categorized into three groups according to the first DUS-detected (index) lesion: (1) normal (peak systolic velocity. [PSV] < 200 cm/s, velocity, ratio [V r] < 2); (2) intermediate stenosis (200 cm/s < PSV < 300 cm/s, 2 < V r < 4); and (3) critical (PSV > 300 cm/s, V r > 4). Our policy was to repair grafts with critical lesions and monitor all others. The risks of stenosis progression, graft revision, and graft thrombosis for each group were compared. Results: Serial DUS was normal in 100 (64%) grafts. The incidence of graft thrombosis in the normal group was 3% per year (mean follow-up, 27.5 months). Intermediate lesions developed in 32 grafts (20%) and were followed. Among these 32 grafts with intermediate stenoses, 63% progressed to critical and were revised, and 32% resolved or stabilized (mean follow-up, 26 months). Only one graft occlusion occurred in grafts with intermediate lesions subjected to serial DUS monitoring (incidence 1.5% per year, P = not significant). In the third group, 16 of 25 grafts with critical lesions were successfully revised and remain patent. In nine cases, critical lesions were not repaired, resulting in seven (78%) occlusions, all within 4 months of DUS detection. Conclusions: Serial surveillance is safe and effective for grafts with intermediate stenoses. The graft occlusion rate for such grafts with careful monitoring is no different from grafts without stenosis, and therefore, arteriography is not indicated in the absence of progression to critical stenosis. The short-term risk of graft occlusion in the presence of an unrevised critical stenosis is nearly 80%. These data have important clinical implications concerning the natural history of vein graft lesions.

Original languageEnglish (US)
Pages (from-to)273-280
Number of pages8
JournalJournal of Vascular Surgery
Volume33
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Natural History
Veins
Pathologic Constriction
Transplants
Angiography
Thrombosis
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

The natural history of intermediate and critical vein graft stenosis : Recommendations for continued surveillance or repair. / Mills, Joseph L; Wixon, Christopher L.; James, Donovan C.; Devine, Jenifer; Westerband, Alex; Hughes, John D.

In: Journal of Vascular Surgery, Vol. 33, No. 2, 2001, p. 273-280.

Research output: Contribution to journalArticle

Mills, Joseph L ; Wixon, Christopher L. ; James, Donovan C. ; Devine, Jenifer ; Westerband, Alex ; Hughes, John D. / The natural history of intermediate and critical vein graft stenosis : Recommendations for continued surveillance or repair. In: Journal of Vascular Surgery. 2001 ; Vol. 33, No. 2. pp. 273-280.
@article{3cefa065472b489fb6af830c18572619,
title = "The natural history of intermediate and critical vein graft stenosis: Recommendations for continued surveillance or repair",
abstract = "Objective: Duplex ultrasound surveillance (DUS) after autogenous lower extremity bypass grafting is controversial. Specific criteria mandating graft revision are not uniform. It has been suggested that grafts harboring critical stenoses undergo revision, whereas those with intermediate stenoses undergo arteriography with selective repair. We sought to define the natural history and determine the risk of graft occlusion associated with unrepaired vein graft stenoses. Methods: We analyzed serial vascular laboratory and clinical data of 156 autogenous infrainguinal vein grafts in 142 patients. Grafts were categorized into three groups according to the first DUS-detected (index) lesion: (1) normal (peak systolic velocity. [PSV] < 200 cm/s, velocity, ratio [V r] < 2); (2) intermediate stenosis (200 cm/s < PSV < 300 cm/s, 2 < V r < 4); and (3) critical (PSV > 300 cm/s, V r > 4). Our policy was to repair grafts with critical lesions and monitor all others. The risks of stenosis progression, graft revision, and graft thrombosis for each group were compared. Results: Serial DUS was normal in 100 (64{\%}) grafts. The incidence of graft thrombosis in the normal group was 3{\%} per year (mean follow-up, 27.5 months). Intermediate lesions developed in 32 grafts (20{\%}) and were followed. Among these 32 grafts with intermediate stenoses, 63{\%} progressed to critical and were revised, and 32{\%} resolved or stabilized (mean follow-up, 26 months). Only one graft occlusion occurred in grafts with intermediate lesions subjected to serial DUS monitoring (incidence 1.5{\%} per year, P = not significant). In the third group, 16 of 25 grafts with critical lesions were successfully revised and remain patent. In nine cases, critical lesions were not repaired, resulting in seven (78{\%}) occlusions, all within 4 months of DUS detection. Conclusions: Serial surveillance is safe and effective for grafts with intermediate stenoses. The graft occlusion rate for such grafts with careful monitoring is no different from grafts without stenosis, and therefore, arteriography is not indicated in the absence of progression to critical stenosis. The short-term risk of graft occlusion in the presence of an unrevised critical stenosis is nearly 80{\%}. These data have important clinical implications concerning the natural history of vein graft lesions.",
author = "Mills, {Joseph L} and Wixon, {Christopher L.} and James, {Donovan C.} and Jenifer Devine and Alex Westerband and Hughes, {John D}",
year = "2001",
doi = "10.1067/mva.2001.112701",
language = "English (US)",
volume = "33",
pages = "273--280",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - The natural history of intermediate and critical vein graft stenosis

T2 - Recommendations for continued surveillance or repair

AU - Mills, Joseph L

AU - Wixon, Christopher L.

AU - James, Donovan C.

AU - Devine, Jenifer

AU - Westerband, Alex

AU - Hughes, John D

PY - 2001

Y1 - 2001

N2 - Objective: Duplex ultrasound surveillance (DUS) after autogenous lower extremity bypass grafting is controversial. Specific criteria mandating graft revision are not uniform. It has been suggested that grafts harboring critical stenoses undergo revision, whereas those with intermediate stenoses undergo arteriography with selective repair. We sought to define the natural history and determine the risk of graft occlusion associated with unrepaired vein graft stenoses. Methods: We analyzed serial vascular laboratory and clinical data of 156 autogenous infrainguinal vein grafts in 142 patients. Grafts were categorized into three groups according to the first DUS-detected (index) lesion: (1) normal (peak systolic velocity. [PSV] < 200 cm/s, velocity, ratio [V r] < 2); (2) intermediate stenosis (200 cm/s < PSV < 300 cm/s, 2 < V r < 4); and (3) critical (PSV > 300 cm/s, V r > 4). Our policy was to repair grafts with critical lesions and monitor all others. The risks of stenosis progression, graft revision, and graft thrombosis for each group were compared. Results: Serial DUS was normal in 100 (64%) grafts. The incidence of graft thrombosis in the normal group was 3% per year (mean follow-up, 27.5 months). Intermediate lesions developed in 32 grafts (20%) and were followed. Among these 32 grafts with intermediate stenoses, 63% progressed to critical and were revised, and 32% resolved or stabilized (mean follow-up, 26 months). Only one graft occlusion occurred in grafts with intermediate lesions subjected to serial DUS monitoring (incidence 1.5% per year, P = not significant). In the third group, 16 of 25 grafts with critical lesions were successfully revised and remain patent. In nine cases, critical lesions were not repaired, resulting in seven (78%) occlusions, all within 4 months of DUS detection. Conclusions: Serial surveillance is safe and effective for grafts with intermediate stenoses. The graft occlusion rate for such grafts with careful monitoring is no different from grafts without stenosis, and therefore, arteriography is not indicated in the absence of progression to critical stenosis. The short-term risk of graft occlusion in the presence of an unrevised critical stenosis is nearly 80%. These data have important clinical implications concerning the natural history of vein graft lesions.

AB - Objective: Duplex ultrasound surveillance (DUS) after autogenous lower extremity bypass grafting is controversial. Specific criteria mandating graft revision are not uniform. It has been suggested that grafts harboring critical stenoses undergo revision, whereas those with intermediate stenoses undergo arteriography with selective repair. We sought to define the natural history and determine the risk of graft occlusion associated with unrepaired vein graft stenoses. Methods: We analyzed serial vascular laboratory and clinical data of 156 autogenous infrainguinal vein grafts in 142 patients. Grafts were categorized into three groups according to the first DUS-detected (index) lesion: (1) normal (peak systolic velocity. [PSV] < 200 cm/s, velocity, ratio [V r] < 2); (2) intermediate stenosis (200 cm/s < PSV < 300 cm/s, 2 < V r < 4); and (3) critical (PSV > 300 cm/s, V r > 4). Our policy was to repair grafts with critical lesions and monitor all others. The risks of stenosis progression, graft revision, and graft thrombosis for each group were compared. Results: Serial DUS was normal in 100 (64%) grafts. The incidence of graft thrombosis in the normal group was 3% per year (mean follow-up, 27.5 months). Intermediate lesions developed in 32 grafts (20%) and were followed. Among these 32 grafts with intermediate stenoses, 63% progressed to critical and were revised, and 32% resolved or stabilized (mean follow-up, 26 months). Only one graft occlusion occurred in grafts with intermediate lesions subjected to serial DUS monitoring (incidence 1.5% per year, P = not significant). In the third group, 16 of 25 grafts with critical lesions were successfully revised and remain patent. In nine cases, critical lesions were not repaired, resulting in seven (78%) occlusions, all within 4 months of DUS detection. Conclusions: Serial surveillance is safe and effective for grafts with intermediate stenoses. The graft occlusion rate for such grafts with careful monitoring is no different from grafts without stenosis, and therefore, arteriography is not indicated in the absence of progression to critical stenosis. The short-term risk of graft occlusion in the presence of an unrevised critical stenosis is nearly 80%. These data have important clinical implications concerning the natural history of vein graft lesions.

UR - http://www.scopus.com/inward/record.url?scp=0035106687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035106687&partnerID=8YFLogxK

U2 - 10.1067/mva.2001.112701

DO - 10.1067/mva.2001.112701

M3 - Article

C2 - 11174778

AN - SCOPUS:0035106687

VL - 33

SP - 273

EP - 280

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -